Strike partnership deal focused on manufacturing and commercialization services
Eversana and Experic, a contract manufacturing organization (CMO) and pharmaceutical supply service company, announced a partnership to enhance clinical development, manufacturing, launch planning and commercialization efforts for life sciences companies.
Per the deal, Experic’s clinical and commercial scale manufacturing and packaging services will be available within Eversana’s platform, which is currently under contract to manage multiple product launches across various therapeutic fields. In 2021, the services will assist in the commercialization of new products or to revitalize the market position and performance of existing branded therapies.
According to the companies, clients will have greater access to end-to-end outsourced services and contracting to improve patient experiences. Eversana’s integrated or stand-alone pharma services intersect multiple areas, ranging from global pricing to patient support.
Experic supports every phase of a product’s life cycle from clinical to commercial scale, across multiple dosing and packaging formats, including capsule filling, powder and pellet dosing (including dry powder inhalation, or DPI), autoinjectors and pen assemblies.